This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Beijing Luzhu Biotechnology Co., Ltd. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Innovation in Vaccination: The Contributions of Pei Hong Jiang
Introduction: Pei Hong Jiang, based in Beijing, China, is an accomplished inventor with a significant contribution to the field of biotechnology. With a focus on developing effective vaccine solutions, Jiang has been instrumental in advancing medical research and therapeutic applications.
Latest Patents: Jiang's notable patent is for a recombinant varicella-zoster virus (VZV) vaccine. This innovative vaccine encompasses a fusion protein that integrates an amino acid sequence from the extracellular domain of a recombinant glycoprotein gE of a live attenuated VZV strain (OKA strain) and an Fc fragment of human immunoglobulin. This groundbreaking formulation demonstrates exceptional immunogenicity and effectively induces high-level expression of neutralizing antibodies in serum, marking a significant step forward in vaccination technology.
Career Highlights: Pei Hong Jiang is currently affiliated with Beijing Luzhu Biotechnology Co., Ltd. In this role, he leverages his expertise to enhance the development of cutting-edge biopharmaceutical products. His work has established him as a key player in the realm of vaccine innovation, earning recognition for his groundbreaking research and the successful application of his patented technologies.
Collaborations: Jiang collaborates closely with talented colleagues, including Jian Kong and Ling Peng. His partnership with these professionals fosters a vibrant environment for innovation and excellence in research, further contributing to the advancements in their shared field.
Conclusion: Pei Hong Jiang's work exemplifies the impact of innovative thinking in biotechnology and its role in public health. His development of a recombinant VZV vaccine showcases the potential for pioneering solutions that address critical health challenges. As he continues to collaborate with leading professionals in the field, Jiang's contributions are poised to make a lasting influence on vaccine development and infectious disease management.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile